Skip to main content

Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy

Abstract

Purpose

Many centers perform catheter ablation for atrial fibrillation (AF) with periprocedural interruption of oral vitamin K antagonists. In this scenario, the optimal post-procedural anticoagulation strategy is still under debate. We sought to compare the incidence of major complications associated with post-procedural use of low molecular weight heparin (LMWH) versus unfractioned heparin (UFH) as a bridge to reinitiation of oral anticoagulation after an AF ablation procedure.

Methods

We retrospectively reviewed medical history data of all patients undergoing catheter ablation for AF at three Spanish referral centers between January 2009 and January 2014. A total of 702 patients were included in the analysis. We compared the incidence of major complications (a combination of major bleeding and thromboembolic events) between patients receiving UFH (291) and those receiving LMWH (411) after the procedure.

Results

The overall incidence of major complications was 4.1 %, including five thromboembolic events (0.7 %) and 24 major bleeding events (3.4 %), with no significant differences in patients treated with LMWH vs. UFH (2.9 vs. 4.1 %; P = NS). The presence of peripheral vascular disease emerged as the only independent predictor of major complications (adjusted odds ratio (OR) 9.1; confidence interval (CI) 95 % 1.7–49.3; P < 0.01).

Conclusions

Immediate post-procedural bridging with UFH or with LMWH are equally safe strategies in patients undergoing catheter ablation for AF in whom oral anticoagulation is interrupted for the procedure. Due to its greater simplicity of use, LMWH may be the preferred option. The presence of peripheral vascular disease is a potent predictor of major post-procedural complications.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

Abbreviations

RFA:

Radiofrequency ablation

AF:

Atrial fibrillation

TE:

Thromboembolic events

References

  1. Jaïs, P., Haïssaguerre, M., Shah, D. C., Chouairi, S., Gencel, L., Hocini, M., et al. (1997). A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation, 95(3), 572–576.

    Article  PubMed  Google Scholar 

  2. Calkins, H. (2012). Catheter ablation to maintain sinus rhythm. Circulation, 125(11), 1439–1445.

    Article  PubMed  Google Scholar 

  3. Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S., et al. (2012). HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace, 14(4), 528–606.

    Article  PubMed  Google Scholar 

  4. Hussein, A. A., Martin, D. O., Saliba, W., Patel, D., Karim, S., Batal, O., et al. (2009). Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm, 6, 1425–1429.

    Article  PubMed  Google Scholar 

  5. Kwak, J. J., Pak, H. N., Jang, J. K., Kim, S. K., Park, J. H., Choi, J. I., Hwang, C., & Kim, Y. H. (2010). Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 21(6), 620–625.

    Article  PubMed  Google Scholar 

  6. Di Biase, L., Burkhardt, J. D., Santangeli, P., Mohanty, P., Sanchez, J. E., Horton, R., Gallinghouse, G. J., Themistoclakis, S., Rossillo, A., Lakkireddy, D., Reddy, M., Hao, S., Hongo, R., Beheiry, S., Zagrodzky, J., Rong, B., Mohanty, S., Elayi, C. S., Forleo, G., Pelargonio, G., Narducci, M. L., Dello Russo, A., Casella, M., Fassini, G., Tondo, C., Schweikert, R. A., & Natale, A. (2014). Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation, 129(25), 2638–2644.

    Article  PubMed  Google Scholar 

  7. Arshad, A., Johnson, C. K., Mittal, S., Buch, E., Hamam, I., Tran, T., Shaw, R. E., Musat, D., Preminger, M., Sichrovsky, T., Herweg, B., Shivkumar, K., Hummel, J., & Steinberg, J. S. (2014). Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study. Pacing and Clinical Electrophysiology, 37(6), 665–673.

    PubMed Central  Article  PubMed  Google Scholar 

  8. Winkle, R. A. (2014). Uninterrupted warfarin anticoagulation for atrial fibrillation ablation: too good to be true? Pacing and Clinical Electrophysiology, 37(6), 661–664.

    Article  PubMed  Google Scholar 

  9. Blanc, J. J., Almendral, J., Brignole, M., Fatemi, M., Gjesdal, K., González-Torrecilla, E., et al. (2008). Scientific Initiatives Committee of the European Heart Rhythm Association. Consensus document on antithrombotic therapy in the setting of electrophysiological procedures. Europace, 10(5), 513–527.

    Article  PubMed  Google Scholar 

  10. Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., & Roth, D. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Annals of Internal Medicine, 130(6), 461–470.

    Article  CAS  PubMed  Google Scholar 

  11. Scherr, D., Sharma, K., Dalal, D., et al. (2009). Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 20(12), 1357–1363.

    Article  PubMed  Google Scholar 

  12. Vazquez, S. R., Johnson, S. A., & Rondina, M. T. (2010). Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation. Thrombosis Research, 126(2), e69–e77.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  13. Cappato, R., Calkins, H., Chen, S. A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y. H., Klein, G., Natale, A., Packer, D., Skanes, A., Ambrogi, F., & Biganzoli, E. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3(1), 32–38.

    Article  PubMed  Google Scholar 

  14. Srivatsa, U. N., Danielsen, B., Anderson, I., Amsterdam, E., Pezeshkian, N., Yang, Y., & White, R. H. (2014). Risk predictors of stroke and mortality after ablation for atrial fibrillation: the California experience 2005-2009. Heart Rhythm, 11(11), 1898–1903.

    Article  PubMed  Google Scholar 

  15. Kosiuk, J., Kornej, J., Bollmann, A., Piorkowski, C., Myrda, K., Arya, A., Sommer, P., Richter, S., Rolf, S., Husser, D., Gaspar, T., Lip, G. Y., & Hindricks, G. (2014). Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors. Heart Rhythm, 11(11), 1934–1940.

    Article  PubMed  Google Scholar 

  16. Dorwarth, U., Fiek, M., Remp, T., Reithmann, C., Dugas, M., Steinbeck, G., & Hoffmann, E. (2003). Radiofrequency catheter ablation: different cooled and noncooled electrode systems induce specific lesion geometries and adverse effects profiles. Pacing and Clinical Electrophysiology, 26(7 Pt 1), 1438–1445.

    Article  PubMed  Google Scholar 

  17. Maleki, K., Mohammadi, R., Hart, D., Cotiga, D., Farhat, N., & Steinberg, J. S. (2005). Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention. Journal of Cardiovascular Electrophysiology, 16(6), 561–565.

    Article  PubMed  Google Scholar 

  18. Wazni, O. M., Rossillo, A., Marrouche, N. F., Saad, E. B., Martin, D. O., Bhargava, M., Bash, D., Beheiry, S., Wexman, M., Potenza, D., Pisano, E., Fanelli, R., Bonso, A., Themistoclakis, S., Erciyes, D., Saliba, W. I., Schweikert, R. A., Brachmann, J., Raviele, A., & Natale, A. (2005). Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. Journal of Cardiovascular Electrophysiology, 16(6), 576–581.

    Article  PubMed  Google Scholar 

  19. Sparks, P. B., Jayaprakash, S., Vohra, J. K., Mond, H. G., Yapanis, A. G., Grigg, L. E., & Kalman, J. M. (1998). Left atrial "stunning" following radiofrequency catheter ablation of chronic atrial flutter. Journal of the American College of Cardiology, 32(2), 468–475.

    Article  CAS  PubMed  Google Scholar 

  20. Di Biase, L., Gaita, F., Toso, E., Santangeli, P., Mohanty, P., Rutledge, N., Yan, X., Mohanty, S., Trivedi, C., Bai, R., Price, J., Horton, R., Gallinghouse, G. J., Beheiry, S., Zagrodzky, J., Canby, R., Leclercq, J. F., Halimi, F., Scaglione, M., Cesarani, F., Faletti, R., Sanchez, J., Burkhardt, J. D., & Natale, A. (2014). Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study. Heart Rhythm, 11(5), 791–798.

    Article  PubMed  Google Scholar 

  21. Deneke, T., Jais, P., Scaglione, M., Schmitt, R., DI Biase, L., Christopoulos, G., Schade, A., Mügge, A., Bansmann, M., Nentwich, K., Müller, P., Krug, J., Roos, M., Halbfass, P., Natale, A., Gaita, F., & Haines, D. (2015). Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. Journal of Cardiovascular Electrophysiology, 26(4), 455–463.

    Article  PubMed  Google Scholar 

  22. Page, S., Herring, N., Hunter, R., Withycombe, E., Lovell, M., Wali, G., Betts, T., Bashir, Y., Dhinoja, M., Earley, M., Sporton, S., Rajappan, K., & Schilling, R. (2014). Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin. Journal of Cardiovascular Electrophysiology, 25, 585–590.

    Article  PubMed  Google Scholar 

  23. Patel, A. A., Clyne, C. A., Henyan, N. N., White, C. M., Zembrowski, B. F., Migeed, M., Yarlagadda, R., Kluger, J., & Coleman, C. I. (2007). The use of protamine after radiofrequency catheter ablation: a pilot study. Journal of Interventional Cardiac Electrophysiology, 18(2), 155–158.

    Article  PubMed  Google Scholar 

  24. Gurses, K. M., Kocyigit, D., Yalcin, M. U., Evranos, B., Yorgun, H., Sahiner, M. L., Kaya, E. B., Oto, M. A., Ozer, N., & Aytemir, K. (2015). Safety and efficacy outcomes of protamine administration for heparin reversal following cryoballoon-based pulmonary vein isolation. Journal of Interventional Cardiac Electrophysiology, 43(2), 161–167.

    Article  PubMed  Google Scholar 

  25. Conte, G., de Asmundis, C., Baltogiannis, G., Di Giovanni, G., Ciconte, G., Sieira, J., Saitoh, Y., Wauters, K., Mugnai, G., Julià, J., Irfan, G., Levinstein, M., Cotino-Moreno, H. E., Chierchia, G. B., & Brugada, P. (2014). Periprocedural outcomes of prophylactic protamine administration for reversal of heparin after cryoballoon ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 41(2), 129–134.

    Article  PubMed  Google Scholar 

  26. Chilukuri, K., Henrikson, C. A., Dalal, D., Scherr, D., MacPherson, E. C., Cheng, A., Spragg, D., Nazarian, S., Sinha, S., Berger, R., Marine, J. E., & Calkins, H. (2009). Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 25(3), 175–181.

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Tomás Datino Romaniega.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Table S1

(DOCX 17 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Loughlin, G., Romaniega, T.D., Garcia-Fernandez, J. et al. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy. J Interv Card Electrophysiol 45, 149–158 (2016). https://doi.org/10.1007/s10840-015-0098-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-015-0098-x

Keywords

  • Atrial fibrillation
  • Radiofrequency ablation
  • Anticoagulation
  • Heparin
  • Protamine